Clinical Trial

Sex-specific Risk Factors and Trajectories of Blood Biomarkers for Alzheimer's Disease and Related Dementias

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Blood-based ADRD biomarkers show tremendous promise as a non-invasive method to predict and diagnose ADRD. We will measure changes in these biomarkers to determine whether their ability to predict ADRD differs by sex or by other characteristics, and develop a sex-specific ADRD risk score for personalized medicine and clinical trials.
Trial Details
NCT Number NCT07224139
Lead Sponsor Anne Murray
Conditions Alzheimer Disease, Dementia, Cognitive Dysfunction
Enrollment 13,435 participants
Start Date 2022-07-01
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2025-11-04